Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Scarpi

Showing results (141-150 of 215) with videos related to

Pageof 22
Sort By:
Breast Cancer Research and Treatment|May 29, 2007
Phase III randomized multicenter study on the effects of adjuvant CMF in patients with node-negative, rapidly proliferating breast cancer: twelve-year results and retrospective subgroup analysisDino Amadori, Oriana Nanni, Annalisa Volpi, et al.
Cancers|January 16, 2020
Erratum: Passardi, A. et al<i>.</i> Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. <i>Cancers</i> 2019, <i>11</i>, 663Alessandro Passardi, Emanuela Scarpi, Elisa Neri, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 6, 2014
Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrenceClaudia Rengucci, Giulia De Maio, Andrea Casadei Gardini, et al.
Cancer Management and Research|June 14, 2019
Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) studyAndrea Casadei-Gardini, Emanuela Scarpi, Paola Ulivi, et al.
Melanoma Research|September 13, 2011
Dendritic cell-based vaccine in advanced melanoma: update of clinical outcomeLaura Ridolfi, Massimiliano Petrini, Laura Fiammenghi, et al.
Oncology Letters|October 5, 2016
RANKL: A promising circulating marker for bone metastasis responseToni Ibrahim, Marianna Ricci, Emanuela Scarpi, et al.
Therapeutic Advances in Medical Oncology|December 21, 2020
Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trialAlessandro Passardi, Ilario Giovanni Rapposelli, Emanuela Scarpi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2016
Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trialMarco Maltoni, Emanuela Scarpi, Monia Dall'Agata, et al.
Frontiers in Oncology|August 9, 2021
Melphalan as a Promising Treatment for BRCA-Related Ovarian CarcinomaVincenza Conteduca, Emanuela Scarpi, Alberto Farolfi, et al.
Journal of Translational Medicine|May 10, 2012
Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: a single center studyPaola Ulivi, Laura Capelli, Martina Valgiusti, et al.
Pageof 22

Showing results (141-150 of 215) with videos related to

Sort By:
Pageof 22
Breast Cancer Research and Treatment|May 29, 2007
Phase III randomized multicenter study on the effects of adjuvant CMF in patients with node-negative, rapidly proliferating breast cancer: twelve-year results and retrospective subgroup analysisDino Amadori, Oriana Nanni, Annalisa Volpi, et al.
Cancers|January 16, 2020
Erratum: Passardi, A. et al<i>.</i> Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. <i>Cancers</i> 2019, <i>11</i>, 663Alessandro Passardi, Emanuela Scarpi, Elisa Neri, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 6, 2014
Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrenceClaudia Rengucci, Giulia De Maio, Andrea Casadei Gardini, et al.
Cancer Management and Research|June 14, 2019
Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) studyAndrea Casadei-Gardini, Emanuela Scarpi, Paola Ulivi, et al.
Melanoma Research|September 13, 2011
Dendritic cell-based vaccine in advanced melanoma: update of clinical outcomeLaura Ridolfi, Massimiliano Petrini, Laura Fiammenghi, et al.
Oncology Letters|October 5, 2016
RANKL: A promising circulating marker for bone metastasis responseToni Ibrahim, Marianna Ricci, Emanuela Scarpi, et al.
Therapeutic Advances in Medical Oncology|December 21, 2020
Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trialAlessandro Passardi, Ilario Giovanni Rapposelli, Emanuela Scarpi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2016
Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trialMarco Maltoni, Emanuela Scarpi, Monia Dall'Agata, et al.
Frontiers in Oncology|August 9, 2021
Melphalan as a Promising Treatment for BRCA-Related Ovarian CarcinomaVincenza Conteduca, Emanuela Scarpi, Alberto Farolfi, et al.
Journal of Translational Medicine|May 10, 2012
Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: a single center studyPaola Ulivi, Laura Capelli, Martina Valgiusti, et al.
Pageof 22